Back

Clinical implications of low-to-intermediate trials for primary prevention of atherosclerotic CVD and risk stratification with N-terminal pro-B-type natriuretic peptide in the Rotterdam Study

6 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1 Epidemiology, lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Doctor Jelena Pavlovic

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

15 More presentations in this session

Presentation thumbnail
Epidemiology/ Public health_Part 1 - Poster discussant:.
Presentation thumbnail
Changes in body weight and composition are associated with changes in left ventricular and atrial geometry in the general population
Presentation thumbnail
Differences in measured and self-reported anthropometric data: the Italian Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 2008-2012
Doctor L. Palmieri (Rome, IT)
Abstract
Presentation thumbnail
Leisure time physical activity initiated by employer and its health effects. A 15-month follow-up study
Doctor M. Skogstad (Oslo, NO)
Abstract
Presentation thumbnail
Serum nitrite and nitrate levels, NOx, in cardiovascular mortality study
Doctor A. Deev (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1

The Event

Event poster

EuroPrevent 2017

6 April - 8 April 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources